August 28, 2017
(Photo Credit - Keith Williamson)
Marrone Bio Innovations, Inc. (NASDAQ:MBII) develops and markets biological products for pest management and plant health.
MBII's recent Q2'17 financial results showed GAAP revenues up 28% and gross margin up for the quarter compared with the same quarter in 2016.
Over 1.2 MM shares of MBII are currently held short.
Related: MBII's Products Legal for CA Cannabis Cultivators
Read our full article on Seeking Alpha
Read more articles tagged:
50 Blue Chip Stocks Worth Less than Half as Much a...
September 19, 2018
5 of Today's Biggest Marijuana Stock Losers -...
September 10, 2018
5 of Today's Biggest Marijuana Stock Gainers -...
September 5, 2018
September 4, 2018
Aphria Partners with Danish Flower Producer
Namaste Announces Medical Cannabis Supply Agreemen...
Aurora Cannabis Closes $200 Million Debt Facility...
August 30, 2018
Trading Marijuana Stocks With Ally Invest
August 7, 2017
2 Marijuana Stocks Added to Russell Microcap Index
June 26, 2017
MBII Products Legal for CA Cannabis Cultivators
June 13, 2017
Trading Marijuana Stocks with Fidelity
April 21, 2017
Trading Marijuana Stocks on E*Trade
April 20, 2017
Trading Marijuana Stocks on the Robinhood App
December 9, 2016